These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 12009211)

  • 1. Characterization of anti-cyclin E single-chain Fv antibodies and intrabodies in breast cancer cells: enhanced intracellular stability of novel sFv-F(c) intrabodies.
    Strube RW; Chen SY
    J Immunol Methods; 2002 May; 263(1-2):149-67. PubMed ID: 12009211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced intracellular stability of sFv-Fc fusion intrabodies.
    Strube RW; Chen SY
    Methods; 2004 Oct; 34(2):179-83. PubMed ID: 15312671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of a new intrabody directed against the N-terminal region of human p53.
    Cohen PA; Mani JC; Lane DP
    Oncogene; 1998 Nov; 17(19):2445-56. PubMed ID: 9824155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Engineering disulfide-linked single-chain Fv dimers [(sFv')2] with improved solution and targeting properties: anti-digoxin 26-10 (sFv')2 and anti-c-erbB-2 741F8 (sFv')2 made by protein folding and bonded through C-terminal cysteinyl peptides.
    McCartney JE; Tai MS; Hudziak RM; Adams GP; Weiner LM; Jin D; Stafford WF; Liu S; Bookman MA; Laminet AA
    Protein Eng; 1995 Mar; 8(3):301-14. PubMed ID: 7479692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Making cell-permeable antibodies (Transbody) through fusion of protein transduction domains (PTD) with single chain variable fragment (scFv) antibodies: potential advantages over antibodies expressed within the intracellular environment (Intrabody).
    Heng BC; Cao T
    Med Hypotheses; 2005; 64(6):1105-8. PubMed ID: 15823695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct phage to intrabody screening (DPIS): demonstration by isolation of cytosolic intrabodies against the TES1 site of Epstein Barr virus latent membrane protein 1 (LMP1) that block NF-kappaB transactivation.
    Gennari F; Mehta S; Wang Y; St Clair Tallarico A; Palu G; Marasco WA
    J Mol Biol; 2004 Jan; 335(1):193-207. PubMed ID: 14659750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid and reliable cloning of antibody variable regions and generation of recombinant single chain antibody fragments.
    Gilliland LK; Norris NA; Marquardt H; Tsu TT; Hayden MS; Neubauer MG; Yelton DE; Mittler RS; Ledbetter JA
    Tissue Antigens; 1996 Jan; 47(1):1-20. PubMed ID: 8929708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cloning of cDNAs encoding the variable domains of antibody KC4G3 and construction of a chimeric antibody.
    Couto JR; Blank EW; Peterson JA; Ceriani RL
    Hybridoma; 1993 Aug; 12(4):485-9. PubMed ID: 8244420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cloning and molecular characterization of human high affinity antibody fragments against Hepatitis C virus NS3 helicase.
    Tessmann K; Erhardt A; Häussinger D; Heintges T
    J Virol Methods; 2002 May; 103(1):75-88. PubMed ID: 11906735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of HIV-1 Tat-mediated LTR transactivation and HIV-1 infection by anti-Tat single chain intrabodies.
    Mhashilkar AM; Bagley J; Chen SY; Szilvay AM; Helland DG; Marasco WA
    EMBO J; 1995 Apr; 14(7):1542-51. PubMed ID: 7537216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medical applications of single-chain antibodies.
    Huston JS; McCartney J; Tai MS; Mottola-Hartshorn C; Jin D; Warren F; Keck P; Oppermann H
    Int Rev Immunol; 1993; 10(2-3):195-217. PubMed ID: 8360586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel selection method for engineered antibodies using the mechanism of Fv fragment stabilization in the presence of antigen.
    Tsumoto K; Nishimiya Y; Kasai N; Ueda H; Nagamune T; Ogasahara K; Yutani K; Tokuhisa K; Matsushima M; Kumagai I
    Protein Eng; 1997 Nov; 10(11):1311-8. PubMed ID: 9514120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cloning of apoB intrabodies: specific knockdown of apoB in HepG2 cells.
    Liao W; Strube RW; Milne RW; Chen SY; Chan L
    Biochem Biophys Res Commun; 2008 Aug; 373(2):235-40. PubMed ID: 18558087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional human monoclonal antibodies of all isotypes constructed from phage display library-derived single-chain Fv antibody fragments.
    Boel E; Verlaan S; Poppelier MJ; Westerdaal NA; Van Strijp JA; Logtenberg T
    J Immunol Methods; 2000 May; 239(1-2):153-66. PubMed ID: 10821956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation of a high affinity scFv from a monoclonal antibody recognising the oncofoetal antigen 5T4.
    Shaw DM; Embleton MJ; Westwater C; Ryan MG; Myers KA; Kingsman SM; Carroll MW; Stern PL
    Biochim Biophys Acta; 2000 Dec; 1524(2-3):238-46. PubMed ID: 11113573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extended half-life and elevated steady-state level of a single-chain Fv intrabody are critical for specific intracellular retargeting of its antigen, caspase-7.
    Zhu Q; Zeng C; Huhalov A; Yao J; Turi TG; Danley D; Hynes T; Cong Y; DiMattia D; Kennedy S; Daumy G; Schaeffer E; Marasco WA; Huston JS
    J Immunol Methods; 1999 Dec; 231(1-2):207-22. PubMed ID: 10648939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of human immunodeficiency virus type 1 replication in vitro in acutely and persistently infected human CD4+ mononuclear cells expressing murine and humanized anti-human immunodeficiency virus type 1 Tat single-chain variable fragment intrabodies.
    Mhashilkar AM; LaVecchio J; Eberhardt B; Porter-Brooks J; Boisot S; Dove JH; Pumphrey C; Li X; Weissmahr RN; Ring DB; Ramstedt U; Marasco WA
    Hum Gene Ther; 1999 Jun; 10(9):1453-67. PubMed ID: 10395371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of anti-mouse Fc gamma RII single-chain Fv fragments derived from human phage display libraries.
    McCall AM; Amoroso AR; Sautès C; Marks JD; Weiner LM
    Immunotechnology; 1998 Jun; 4(1):71-87. PubMed ID: 9661816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The construction of a mouse/human chimeric antibody against human breast cancer cells.
    Meulemans E; Vandevyver C; Volckaert G; Raus J
    Year Immunol; 1993; 7():131-6. PubMed ID: 8372502
    [No Abstract]   [Full Text] [Related]  

  • 20. Molecular cloning of a monoclonal anti-tumor antibody specific for the Tn antigen and expression of an active single-chain Fv fragment.
    Babino A; Pritsch O; Oppezzo P; Du Pasquier R; Roseto A; Osinaga E; Alzari PM
    Hybridoma; 1997 Aug; 16(4):317-24. PubMed ID: 9309422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.